Isu Abxis Co Ltd banner
I

Isu Abxis Co Ltd
KOSDAQ:086890

Watchlist Manager
Isu Abxis Co Ltd
KOSDAQ:086890
Watchlist
Price: 4 830 KRW 0.84%
Market Cap: ₩196.7B

Isu Abxis Co Ltd
Investor Relations

ISU Abxis Co., Ltd. engages in the provision of pharmaceutical products. The company is headquartered in Seongnam, Gyeonggi-Do and currently employs 143 full-time employees. The company went IPO on 2009-02-03. The firm operates its business under two divisions: antibody therapeutics business division and diagnostic business division. Its antibody therapeutics business division engages in the development of Cloticab, which is a monoclonal therapeutic antibody for thrombus. Its diagnostic business division engages in the provision of genetic testing services and chemotherapy response assay services for cancer examination.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Sang-Ho Park Ph.D.
Chief Exec. Officer
No Bio Available
Jae-Heung Lee
Exec.
No Bio Available

Contacts

Address
GYEONGGI-DO
Seongnam
5F, 4F, C Dong, Global R&D Center, 22, Daewangpangyo-ro 712beon-gil, Bundang-gu
Contacts
+82316964700
www.abxis.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett